NYSE:ANVS | Cash Flow Statement | Annovis Bio, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$14.82M
2026-03-31-$17.61M-$9.01M$3.7M
2025-12-31-$9.83M-$8.93M$13.17M
2025-09-30-$7.26M
2025-06-30-$6.22M
2025-03-31-$5.54M-$8.1M$19.78M
2024-12-31-$5.86M-$8.29M$6.2M
2024-09-30-$12.64M
2024-06-30-$5.02M
2024-03-31-$1.07M-$7.03M$4.42M
2023-12-31-$22.21M-$9.36M$8.76M
2023-09-30-$14.72M
2023-06-30-$9.54M
2023-03-31-$9.74M-$11.63M$7,386.00
2022-12-31-$7.73M-$3.61M$0.00
2022-09-30-$6.43M
2022-06-30-$5.94M
2022-03-31-$5.23M-$3.02M$4,613.00
2021-12-31-$5.91M-$1.77M$0.00
2021-09-30-$2.85M
2021-06-30-$2.52M
2021-03-31-$3.2M-$2.47M$3,017.00
2020-12-31-$1.7M-$765,949.00$0.00
2020-09-30-$1.01M
2020-06-30-$2.31M
2020-03-31-$441,590.00-$970,405.00$12.09M
2019-12-31-$201,256.00-$52,528.00-$1,864.00
2019-09-30-$254,121.00
2019-06-30-$344,700.00
2019-03-31-$190,903.00-$228,739.00$530,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$28.85M-$25.62M$34.6M
2024-12-31-$24.59M-$21.89M$26.69M
2023-12-31-$56.2M-$39.97M$17.34M
2022-12-31-$25.33M-$17.31M$4,613.00
2021-12-31-$14.49M-$9.13M$46.74M
2020-12-31-$5.46M-$3.97M$12.04M
2019-12-31-$990,980.00-$476,542.00$443,088.00